Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 6/20 | 0.57 |
| ▸ | TK1 | P04183 | 2/20 | 0.57 |
| ▸ | PNP | P00491 | 7/20 | 0.56 |
| ▸ | BLM | P54132 | 2/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | EDNRA | P25101 | 1/20 | 0.56 |
| ▸ | HTR2A | P28223 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | HBB | P68871 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | VCP | P55072 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL9697806 | 0.98 | XDH (0.56) | XDHTK1PNPBLMUSP2 | |
| SCHEMBL986800 | 0.82 | XDH (0.60) | XDHTK1PNPBLMUSP2 | |
| SCHEMBL15005119 | 0.81 | XDH (0.59) | XDHTK1PNPBLMUSP2 | |
| SCHEMBL27667185 | 0.81 | XDH (0.63) | XDHTK1PNPBLMUSP2 | |
| SCHEMBL41787 | 0.81 | XDH (0.59) | XDHTK1PNPBLMUSP2 | |
| SCHEMBL27923065 | 0.80 | XDH (0.55) | XDHTK1PNPBLMUSP2 | |
| SCHEMBL27541246 | 0.80 | XDH (0.58) | XDHTK1PNPBLMUSP2 | |
| SCHEMBL2051364 | 0.79 | XDH (0.57) | XDHTK1PNPBLMUSP2 | |
| SCHEMBL10835122 | 0.79 | XDH (0.61) | XDHTK1PNPBLMUSP2 | |
| SCHEMBL22533906 | 0.79 | XDH (0.57) | XDHTK1PNPBLMUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115769078-A | Compositions with improved specificity and sensitivity for ovarian cancer assessment | 艾思彼拉妇女保健公司 | 2023-03-07 | — | — | CN | claimed |
| CN-106442958-A | Atmospheric particulate toxicity study method and system thereof | 北京大学 | 2017-02-22 | — | — | CN | claimed |
| US-20260139247-A1 | ENGINEERED ENVELOPED VECTORS AND METHODS OF USE THEREOF | GIGAMUNE INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12631621-B2 | Ligand discovery and gene delivery via retroviral surface display | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2026-05-19 | — | — | US | disclosed |
| US-12631622-B2 | Ligand discovery and gene delivery via retroviral surface display | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260029398-A1 | LIGAND DISCOVERY AND GENE DELIVERY VIA RETROVIRAL SURFACE DISPLAY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2026-01-29 | — | — | US | disclosed |
| US-20260029399-A1 | LIGAND DISCOVERY AND GENE DELIVERY VIA RETROVIRAL SURFACE DISPLAY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2026-01-29 | — | — | US | disclosed |
| US-12501868-B2 | Haploid induction compounds and methods for use thereof | WIMI BIOTECHNOLOGY (HAINAN) CO., LTD. (CN) | 2025-12-23 | — | — | US | disclosed |
| US-12455280-B2 | Ligand discovery and gene delivery via retroviral surface display | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-10-28 | — | — | US | disclosed |
| US-12371689-B2 | Engineered enveloped vectors and methods of use thereof | GIGAMUNE, INC. (US) | 2025-07-29 | — | — | US | disclosed |
| EP-4580664-A1 | ENGINEERED ENVELOPED VECTORS AND METHODS OF USE THEREOF | Gigamune, Inc. (US) | 2025-07-09 | — | — | EP | disclosed |
| US-20030167524-A1 | Methods for the production of multimeric protein complexes, and related compositions | SEMBIOSYS GENETICS, INC. (CA) | 2003-09-04 | — | — | US | disclosed |
| US-20030093832-A1 | Methods for the production of multimeric immunoglobulins, and related compositions | SEMBIOSYS GENETICS INC. (CA) | 2003-05-15 | — | — | US | disclosed |
| WO-2002050289-A9 | METHODS FOR THE PRODUCTION OF MULTIMERIC PROTEINS, AND RELATED COMPOSITIONS | SEMBIOSYS GENETICS INC (CA) | 2003-04-17 | — | — | WO | disclosed |
| WO-2003002564-A1 | IMPROVED SYNTHESIS OF BRANCHED ACYCLIC NUCLEOSIDES | MEDIVIR AB (SE) | 2003-01-09 | — | — | WO | disclosed |
| WO-2002050289-A1 | METHODS FOR THE PRODUCTION OF MULTIMERIC PROTEINS, AND RELATED COMPOSITIONS | SEMBIOSYS GENETICS, INC. (CA) | 2002-06-27 | — | — | WO | disclosed |
| WO-2002030266-A2 | DETECTION OF DNA DAMAGE | ESA, INC. (US) | 2002-04-18 | — | — | WO | disclosed |
| WO-2002031189-A2 | MODEL SYSTEM FOR THE VIVO STUDY OF APOPTOSIS | EIRX THERAPEUTIC LIMITED (IE) | 2002-04-18 | — | — | WO | disclosed |
| US-20020037303-A1 | Thioredoxin and thioredoxin reductase containing oil body based products | SEMBIOSYS GENETICS INC. (CA) | 2002-03-28 | — | — | US | disclosed |
| WO-1996024688-A1 | DIAGNOSTICS BASED ON DNA DUPLEX REPAIR | MOSAIC TECHNOLOGIES (US) | 1996-08-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139247-A1 | ENGINEERED ENVELOPED VECTORS AND METHODS OF USE THEREOF | TMIGD3, TMPRSS11D, TMED2 | XDH 1291/4885TK1 2648/4885PNP 2068/4885 |
| US-20260029399-A1 | LIGAND DISCOVERY AND GENE DELIVERY VIA RETROVIRAL SURFACE DISPLAY | VSIG8, TMIGD3, LDLR | XDH 4303/4885TK1 1675/4885PNP 3119/4885 |
| US-20260029398-A1 | LIGAND DISCOVERY AND GENE DELIVERY VIA RETROVIRAL SURFACE DISPLAY | LDLR, TMIGD3, VSIG8 | XDH 3946/4885TK1 1717/4885PNP 2954/4885 |
| US-12631622-B2 | Ligand discovery and gene delivery via retroviral surface display | VSIG8, TMIGD3, CD4 | XDH 4183/4885TK1 1260/4885PNP 3251/4885 |
| US-12631621-B2 | Ligand discovery and gene delivery via retroviral surface display | TMIGD3, LDLR, VSIG8 | XDH 3987/4885TK1 1395/4885PNP 2949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.